---
title: Eurofins Central Laboratory vs Lambda Therapeutic Research
slug_a: eurofins
slug_b: lambda-cro
site: cdmo
review_signal_gate: closed
canonical_path: /compare/eurofins/lambda-cro
---

# Eurofins Central Laboratory vs Lambda Therapeutic Research

Side-by-side profile data from each company listing on this directory.

## Eurofins Central Laboratory

- Profile: [/companies/eurofins](/companies/eurofins)

Eurofins Central Laboratory — Global network of over 950 laboratories across 57 countries offering comprehensive contract research, testing, and manufacturing services including BioPharma discovery, bioanalysis, Phase I clinics, CDMO, central laboratory services, and specialized analytical testing.

Services: 7. Modalities: 0. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (7).

### Services

- Bioanalysis
- Phase I Clinical Trials
- Central Laboratory Services
- Analytical Method Development & Validation
- ICH Stability Studies
- Translational Research
- Genomics & Sequencing Services

### Modalities

- Data not yet provided.

### Development capabilities

- Data not yet provided.

### Manufacturing capabilities

- Data not yet provided.

## Lambda Therapeutic Research

- Profile: [/companies/lambda-cro](/companies/lambda-cro)

Lambda Therapeutic Research — Full-service global CRO offering Phase I–IV clinical trial management, pharmacovigilance, and bioanalytical labs, plus biologics CDMO services. Has supported 280+ clinical trials across 15+ therapeutic domains.

Services: 13. Modalities: 1. Indications: 10. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (13).

### Services

- Bioanalysis
- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Clinical Imaging Core Lab
- Regulatory Affairs

### Modalities

- Biologics (Other)

### Development capabilities

- Data not yet provided.

### Manufacturing capabilities

- Data not yet provided.